A detailed history of Hsbc Holdings PLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 54,554 shares of NPCE stock, worth $700,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,554
Previous 59,248 7.92%
Holding current value
$700,473
Previous $660,000 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$8.25 - $10.6 $38,725 - $49,756
-4,694 Reduced 7.92%
54,554 $570,000
Q2 2025

Aug 13, 2025

BUY
$10.34 - $18.13 $612,624 - $1.07 Million
59,248 New
59,248 $660,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $319M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.